PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) announced its earnings results on Thursday. The company reported ($0.90) EPS for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.31), MarketWatch Earnings reports. PHAS stock opened at $1.14 on Friday. The business has a 50 day simple moving average of $1.46 and a 200-day simple moving average […]